The major obstacle of differential display is not the technique itself but rather the post-differential display issue of discriminating between false positives and the truly differentially expressed mRNAs. This process is arduous and requires large amounts of RNA. We present and validate a method which allows one to screen putative positives from differential display analysis using only micrograms of total RNA. More importantly, we demonstrate that cDNA probes generated from amplified RNA are representative of the starling mRNA population and can be used for differential screening of mRNA species at a detectable limit of sensitivity of .1140 000.
Differential display (DD; 1-3) is currently the method of choice among many investigators for identifying differentially expressed mRNAs because it identities mRNAs independent of prevalence, uses small amounts of RNA (<5 gg total RNA), identifies both increases and decreases of mRNA levels and has rapid output (4) . As stated by Debouck (5) , the downstream verification process for DD is the most time consuming and requires significant amounts of RNA (i.e., a great deal more RNA than actually needed to perform the initial differential display analysis).
In genera', DD can generate many fa1se positives and therefore without a high throughput method to screen for the truly differentially expressed cDNAs, the investigator can easily be overwhelmed. Screening methods such as Northem assay, RNase protection assay, quantitative PCR, differential screening (6) and in situ hybridization are usually not optima" for large scale screening operations because of either the large amounts of RNA required and/or the necessity to test each putative positive one at a time.
Here we present and validate an improved screening method that combines differential screening with the use of amplified RNA (aRNA) (7, 8 ) generated from 5 1.1g total RNA. The use of radiolabeled amplified RNA (aRNA) has already been shown to enable the detection of differential expression of mRNAs (7, 8) . However, an examination to determine whether aRNA is representative of the original mRNA population has not been published. In addition, for use as a screening tool for putative positives from DD analysis, the original aRNA method has two disadvantages: (i) in our hands, RNA probes produce higher backgrounds than cDNA probes, and (ii) because the aRNA is labeled, it has a short half-life. As shown below, to avoid these problems we have generated cDNA probes from unlabeled aRNA that was obtained from total RNA and demonstrate that such cDNA probes are representative of the starting mRNA population [i.e. poly(A)1, and can be used to detect mRNA expression with a limit of sensitivity of at least 1:40 000.
To validate this method, we chose 10 distinct cDNAs previously identified by differential display as either differentially expressed (clones [1] [2] [3] [4] [5] or unchanged (clones 6-10) in HeLa cells in response to interferon-y (IFN-y) treatment (4). Each cDNA was spotted onto four replicas of nylon membrane at five concentrations ranging from 60 ng to 6 p.g. Four cDNA-labeled probes were synthesized from either 2 1..1g poly(A) RNA extracted from untreated or IFN-y-treated cells, or 2 lig aRNA (amplified from 5 lig total RNA) from untreated or IFN-y-treated cells. Total RNA was prepared using RNAzol B solution (Tell-Test) and mRNA was prepared from total RNA using FastTrack 2.0 mRNA Isolation kit (InVitrogen).
RNA amplification was performed following a previously described protocol (8) with a few modifications. Double-stranded cDNA was made using 5 !_tg total RNA from untreated or IFN-ystimulated HeLa cells, and 94 ng of T7(dT)15, (5'-AAA CGA CGG CCA GTG AAT TGT AAT ACG ACT CAC TAT AGG CGC T15-3') using the Superscript Plasmid System for cDNA Synthesis (Gibco BRL). The cDNA was blunt-ended with T4 DNA polymerase; the reaction was stopped by incubation at 65°C for 10 min. The cDNA was then precipitated by ethanol precipitation in the presence of ammonium acetate and resuspended in H20. RNA amplification was performed with the whole cDNA reaction using the Ampliscribe T7 Transcription kit (Epicentre). Incubation was carried out for 4 h at 37°C and the aRNA was precipitated with ammonium acetate as follows: 0.5 vol 7.5 M ammonium acetate was added (no ethanol is added) to the reaction, the mixture was chilled on ice for 15 min, and centrifuged at 14 000 r.p.m. for 30 min at room temperature, and the subsequent aRNA pellet was resuspended in H20 (using this precipitation method effectively eliminates free nucleotides). 32P-labeled cDNA probes were made with 2 lig poly(A) RNA or aRNA using Superscript Preamplification System (MMLV-reverse transcriptase; Gibco BRL). The primer consisted of 1 i_tg oligo (dT)12-18 (Gibco BRL) when poly(A) RNA was used and 740 ng random hexamers pd(N)6 (Pharmacia) when aRNA was used. The reaction was performed in 25 lil final volume using 2. Figure 2 . Sensitivity of differential screening performed with a 32P-labeled cDNA probe generated from aRNA. CD14 cRNA was added to untreated HeLa cells aRNA at molar ratios of 1/10 000, 1/20 000 and 1/40 000. Clones #4 and #6 are negative and positive controls respectively (Fig. 1) .
3N NaOH. The mixture was neutralized by adding 10 IA 1 M Tris-HC1 (pH 7.4), 31.11 2N HC1 and 9 [..11 H20. Unincorporated nucleotides were removed by passage through a G50 Sephadex column (Boehringer Mannheim). Plasmid DNAs (Fig. 1 ) or cDNA inserts amplified by PCR (Fig. 2 ) from clones 1-10 were transfered onto a nylon membrane (Maximum Strength Nytran, 0.45 mm; Schleicher & Schuell) using a 96-well Dot Filtration Manifold System (Gibco BRL). DNA was then denatured once for 5 min at room temperature (1.5 M NaCl, 0.5 M NaOH), neutralized twice for 5 min at room temperature (1.5 M NaC1, 1 M Tris-HC1 pH 7.4), rinsed in 2x SSC and finally UV cross-linked once in a UV-stratalinker 2400 (Stratagene). Membranes were pre-hybridized in 1 x Southern pre-hybridization buffer (5 Prime to 3 Prime, Inc.) containing 50% formamide and 100 lig/mi sheared salmon sperm DNA ovemight at 42°C. Hybridization was performed in 1 x Southern hybridization buffer containing 50% formamide and 100 p,g/m1 sheared salmon sperm DNA (5 Prime to 3 Prime, Inc.) ovemight at 42°C in the presence of 107 c.p.m./m1cDNA probe. Blots were placed onto a phosphor screen for 1 day and results were analyzed using a PhosphorImager 445SI (Molecular Dynamics).
As shown in Figure 1 , similar results are observed with cDNA-labeled probes derived from either unamplified or amplified RNA. Quantitative analysis of the hybridization via the PhosphorImager 445S1 (data not shown) confirmed this observation: the relative signal intensities obtained with poly(A) RNA-derived probes were similar to the one obtained with aRNA-derived probes. However the overall specific activity of the aRNA-derived probes was, to some extent, lower than the one of poly(A)-derived probes, which is probably due to the fact that aRNA has a higher level of ribosomal RNA contamination than poly(A) RNA. In a subsequent experiment we have found similar results with 45 additional cDNAs from the HeLa +/-1FN-y paradigm (data not shown). Yields of aRNA from 51.tg total RNA range from 10 to 50 pg. With 10 lig aRNA, five cDNA probes can be synthesized and 10 96-well format spotted membranes probed (two membranes back-to-back hybridization); thus at least 960 cDNAs can be differentially screened from 5 gg total RNA.
With regard to sensitivity, there is an obvious correlation between DNA concentration and sensitivity [similar results were found with amplified (PCR) inserts, data not shown]. In addition, the limit of detection for determining a differentially expressed mRNA appears to be between the prevalences of clone 3, which shows a 2.5-fold up-regulation and clone 4 which shows a 2.2-fold up-regulation, whereas the maximum difference observed for the negative controls is 1.3-fold (quantitative results obtained when 6 [,tg DNA is spotted onto nylon membrane, data not shown). Clones 1,2 and 3 previously have been found to have a prevalence of 1/1500, 1/7800 and 1/54 000 respectively (4). To test the limit of detection directly, defined amounts of cRNA synthesized from human CD14 cDNA (not expressed in HeLa cells) were added to untreated HeLa cell aRNA prior to probe synthesis. As shown in Figure 2 , the limit of the prevalence at which CD14 can be detected is at least 1/40 000 at which the detection signal is 7.5-fold the background signal.
In conclusion, we validate the use of aRNA in the differential screening method and demonstrate that this method can be used to detect mRNA with a frequency as low as 1/ 40 000. This method will complement one of the main pitfalls of differential display and allow a wider use of the technique.
